๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Mesalazine - Medicines in Ireland

41 authorised products containing Mesalazine, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 41 authorised medicines
MedicineActive substanceLicence holderStatus
Asacolon 1000 mg Suppository
PA2018/005/001
Mesalazine Tillotts Pharma GmbH Marketed
Asacolon 1600 mg modified-release tablets
PA2018/004/001
Mesalazine Tillotts Pharma GmbH Marketed
Asacolon 400mg Gastro-Resistant Tablets
PA2018/001/001
Mesalazine Tillotts Pharma GmbH Marketed
Asacolon 500 mg Suppositories
PA2018/001/003
Mesalazine Tillotts Pharma GmbH Marketed
Asacolon 800 mg Gastro-resistant Tablets
PPA0465/465/001
Mesalazine PCO Manufacturing Ltd. โ€”
Asacolon 800mg Gastro-resistant Tablets
PA2018/001/002
Mesalazine Tillotts Pharma GmbH Marketed
Galtasa 1000 mg gastro-resistant tablets
PA0864/001/003
Mesalazine Faes Farma S.A. Not marketed
Galtasa 500 mg gastro-resistant tablets
PA0864/001/001
Mesalazine Faes Farma S.A. Not marketed
Galtasa 500 mg suppositories
PA0864/001/002
Mesalazine Faes Farma S.A. Not marketed
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets
PA23211/004/001
Mesalazine Takeda Pharmaceuticals International AG Ireland Branch Marketed
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets
PPA0465/289/001
Mesalazine PCO Manufacturing Ltd. โ€”
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets
PPA1463/093/001
Mesalazine IMED Healthcare Ltd., โ€”
Mezavant XL 1200 mg gastro-resistant, prolonged release tablets
PPA2306/023/001
Mesalazine Originalis B.V. โ€”
Pentasa 1 g prolonged-release tablets
PA1009/006/007
Mesalazine Ferring Ireland Ltd Marketed
Pentasa 1 g prolonged-release tablets
PPA1463/110/002
Mesalazine IMED Healthcare Ltd. โ€”
Pentasa 1 g prolonged-release tablets
PPA0465/450/003
Mesalazine PCO Manufacturing Ltd. โ€”
Pentasa 1 g suppositories
PPA2306/010/001
Mesalazine Originalis B.V. โ€”
Pentasa 1 g Suppositories
PPA1463/190/003
Mesalazine IMED Healthcare Ltd., โ€”
Pentasa 10 mg/ml Rectal Suspension
PA1009/006/003
Mesalazine Ferring Ireland Ltd Marketed
Pentasa 1g Suppositories
PA1009/006/002
Mesalazine Ferring Ireland Ltd Marketed
Pentasa 1g Suppositories
PPA0465/450/005
Mesalazine PCO Manufacturing Ltd. โ€”
Pentasa 500 mg prolonged-release tablets
PA1009/006/005
Mesalazine Ferring Ireland Ltd Marketed
Pentasa 500 mg prolonged-release tablets
PPA1463/110/001
Mesalazine IMED Healthcare Ltd., โ€”
Pentasa Sachet 1g prolonged-release granules
PA1009/006/001
Mesalazine Ferring Ireland Ltd Marketed
Pentasa Sachet 1g prolonged-release granules
PPA0465/450/006
Mesalazine PCO Manufacturing Ltd. โ€”
Pentasa Sachet 2 g prolonged-release granules
PPA0465/450/001
Mesalazine PCO Manufacturing Ltd. โ€”
Pentasa Sachet 2 g prolonged-release granules
PPA1463/190/001
Mesalazine IMED Healthcare Ltd., โ€”
Pentasa Sachet 2g prolonged-release granules
PA1009/006/006
Mesalazine Ferring Ireland Ltd Marketed
Pentasa Sachet 2g prolonged-release granules
PPA2306/010/002
Mesalazine Originalis B.V. โ€”
Pentasa Sachet 4 g prolonged-release granules
PPA0465/450/004
Mesalazine PCO Manufacturing Ltd. โ€”
Pentasa Sachet 4 g prolonged-release granules
PPA1463/190/002
Mesalazine IMED Healthcare Ltd., โ€”
Pentasa Sachet 4 g Prolonged-release granules
PA1009/006/008
Mesalazine Ferring Ireland Ltd Marketed
Salofalk 1.5g prolonged-release granules
PA0573/003/007
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 1000mg prolonged-release granules
PA0573/003/002
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 1g Suppositories
PA0573/004/004
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 1g Suppositories
PPA1463/212/001
Mesalazine IMED Healthcare Ltd., โ€”
Salofalk 1g/Actuation Rectal Foam
PA0573/004/005
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 250 mg Suppositories
PA0573/004/002
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 3g prolonged-release granules
PA0573/003/006
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 4g/60ml Enema
PA0573/004/001
Mesalazine Dr. Falk Pharma GmbH Marketed
Salofalk 500 mg prolonged-release granules
PA0573/003/001
Mesalazine Dr. Falk Pharma GmbH Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.